- Home
- HTLM vs CSBR Comparison
HTLM vs CSBR Comparison
Compare HTLM & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLM
- CSBR
- Stock Information
- Founded
- HTLM 2014
- CSBR 1985
- Country
- HTLM Singapore
- CSBR United States
- Employees
- HTLM N/A
- CSBR N/A
- Industry
- HTLM
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HTLM
- CSBR Health Care
- Exchange
- HTLM NYSE
- CSBR Nasdaq
- Market Cap
- HTLM 117.5M
- CSBR 98.1M
- IPO Year
- HTLM 2024
- CSBR 1986
- Fundamental
- Price
- HTLM $7.99
- CSBR $9.78
- Analyst Decision
- HTLM
- CSBR Strong Buy
- Analyst Count
- HTLM 0
- CSBR 1
- Target Price
- HTLM N/A
- CSBR $8.00
- AVG Volume (30 Days)
- HTLM 103.1K
- CSBR 79.1K
- Earning Date
- HTLM 12-25-2024
- CSBR 03-11-2025
- Dividend Yield
- HTLM N/A
- CSBR N/A
- EPS Growth
- HTLM N/A
- CSBR N/A
- EPS
- HTLM N/A
- CSBR N/A
- Revenue
- HTLM $4,563,246.00
- CSBR $53,571,000.00
- Revenue This Year
- HTLM N/A
- CSBR $14.19
- Revenue Next Year
- HTLM N/A
- CSBR $10.11
- P/E Ratio
- HTLM N/A
- CSBR N/A
- Revenue Growth
- HTLM N/A
- CSBR 7.19
- 52 Week Low
- HTLM $2.57
- CSBR $3.60
- 52 Week High
- HTLM $13.74
- CSBR $10.90
- Technical
- Relative Strength Index (RSI)
- HTLM N/A
- CSBR 64.37
- Support Level
- HTLM N/A
- CSBR $9.00
- Resistance Level
- HTLM N/A
- CSBR $10.90
- Average True Range (ATR)
- HTLM 0.00
- CSBR 0.88
- MACD
- HTLM 0.00
- CSBR -0.05
- Stochastic Oscillator
- HTLM 0.00
- CSBR 66.67
About HTLM HOMESTOLIFE LTD
Homestolife Ltd is a home furniture retailers that offers and sells customized furniture solutions in Singapore. It has six retail store locations that sell furniture manufactured from China and other Asian countries.
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.